A pivotal moment occurred in October 2022, just four months after Mounjaros launch, when Elon Musk admitted on Twitter (X) that taking Wegovy was his secret for looking fit and healthy. The post, and a subsequent tweet in 2024 that he was taking Mounjaro, went viral and sparked widespread curiosity around GLP-1s and their effectiveness on weight loss
Initial assessment begins with a thorough clinical history exploring dietary habits, medication use, gastrointestinal symptoms, and family history of autoimmune conditions
Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
Substantial shares of these firms provide incentives for workers to participate in or complete the programs
GLP-1s come with side effects and they can get more intense with higher doses
In practice, the choice is rarely one-size-fits-all